Rona Ortenberg
Ramat Gan, TA 52626, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Circulating microRNA signatures as potential biomarkers differentiating diabetic, prediabetic, and healthy individuals.
Journal: Frontiers in endocrinology
Published: September 04, 2025
microRNA expression patterns in tumor infiltrating lymphocytes are strongly associated with response to adoptive cell transfer therapy.
Journal: Cancer immunology, immunotherapy : CII
Published: April 25, 2020
Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients.
Journal: Science (New York, N.Y.)
Published: March 06, 2020
Immune co-culture cell microarray - a feasible tool for high-throughput functional investigation of lymphocyte-cancer interactions.
Journal: Oncoimmunology
Published: September 28, 2019
Proteomics of Melanoma Response to Immunotherapy Reveals Mitochondrial Dependence.
Journal: Cell
Published: March 22, 2019
Regulation of CEACAM1 Protein Expression by the Transcription Factor ETS-1 in BRAF-Mutant Human Metastatic Melanoma Cells.
Journal: Neoplasia (New York, N.Y.)
Published: November 20, 2017
ADAR1-mediated regulation of melanoma invasion.
Journal: Nature communications
Published: February 07, 2017
SOX9 indirectly regulates CEACAM1 expression and immune resistance in melanoma cells.
Journal: Oncotarget
Published: November 01, 2015
Serum CEACAM1 Elevation Correlates with Melanoma Progression and Failure to Respond to Adoptive Cell Transfer Immunotherapy.
Journal: Journal of immunology research
Published: July 16, 2015
Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack.
Journal: Immunity
Published: October 05, 2014
A longitudinal study of CEACAM1 expression in melanoma disease progression.
Journal: Oncology reports
Published: October 01, 2014
Last Updated: 09/26/2026